Life Science Compliance Update

November

2015

November 2015: Life Science Compliance Update

Written by , Posted in New This Month, November 2015 LSC, This Month in Compliance

The full text of the entire issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.

October 2015 LSCU Cover

Issue Summary

The November issue features an article on the latest qui tam case involving Takeda, which breaks new ground as the plaintiff is a customer as well as an investigative author.  Nicodermo (Nico) Fiorentino, Senior Advisor, Research & Compliance, for G&M Health LLC., contributed a great roundup on the EU Data Privacy and the impact of the invalidation of the US-EU Safe Harbor Framework.  We also take a look at the state of medical device preemption after the case of Caplinger v. Medtronic, Inc., and delve into the muddy waters of FDA’s social media guidance.

Finally, in a new section called the Editor’s Corner, our new editor, Seth Whitelaw reflects on what it takes to find and engage a good life sciences compliance officer.

Table of Contents

Arrow

Letter from the Editor

Arrow

Editor’s Corner: Reflections On Finding and Engaging a Good Compliance Officer

Arrow

Litigation: Takeda Qui Tam Breaks New Ground

Arrow

Data Privacy: Sailing with No Safe Harbor In Sight:  What is the Next Destination for US-EU Data Privacy?

Arrow

Medical Devices: Federal Preemption and Medtronic: The Seemingly Endless Merry-Go Round

Arrow

Social Media: A Journey Without End? FDA and Social Media Guidance

Arrow

Transparency: Academics On The Board – A True Problem Or A Hammer Looking For A Nail?

Arrow

Briefly Noteworthy

  • Who says crime doesn’t pay
  • Whistleblowing UK-style
  • Getting it backwards – guilty until proven innocent
  • Even the government cheats
Menu Title